NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)

NCI 社区肿瘤​​学研究计划 (NCORP) 社区站点（需要 UG1 临床试验）

• 批准号: 10676138
• 负责人: JOHN A ELLERTON
• 金额: $ 182.02万
• 依托单位: SOUTHERN NEVADA CANCER RESEARCH FDN
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10676138
• 关键词: Acceleration; Address; Adolescent and Young Adult; Advocate; Aftercare; California; Cancer Control; Caring; Cities; Clinical Trials; Collection; Communities; Community Clinical Oncology Program; Community Participation; Data; Development; Discipline; Disparity; Early Diagnosis; Educational Activities; Elderly; Enrollment; Environment; Ethnic Origin; Foundations; Funding Opportunities; Goals; Health Personnel; Hematologist; Image; Incidence; Maintenance; Malignant Neoplasms; Medical; Michigan; Mission; Morbidity - disease rate; Names; National Cancer Institute; Nevada; Oncologist; Participant; Patients; Physicians; Population; Prevention; Protocols documentation; Quality of life; Race; Radiation Oncologist; Research; Research Activity; Research Design; Research Personnel; Resources; Safety; Sexual and Gender Minorities; Site; Technology; Time; Underrepresented Populations; Underserved Population; Work; anticancer research; base; biobank; cancer care; cancer health disparity; cancer prevention; cancer therapy; care delivery; clinical trial enrollment; clinical trial participant; clinically significant; community based research; ethnic minority; gender minority; health related quality of life; high standard; insight; interest; medical specialist; member; mortality; participant enrollment; programs; protocol development; racial minority; rehabilitation management; research study; rural dwellers; screening; welfare

The Nevada Cancer Research Foundation (NCRF) was established in 1983 to conduct cancer research. The NCRF main office is located in Las Vegas with satellite offices in Reno and Carson City, Nevada and Arroyo Grande, California and Port Huron, Michigan. Over 80% of the oncologists, hematologists and radiation oncologists in Nevada are investigator members of the NCRF and participate in NCI clinical trials and projects. NCRF’s primary mission is to provide quality and state-of-the-art cancer treatment in Nevada through participation in active cancer research studies for the residents of Nevada through the participation of the local physicians and health care providers. NCRF also has as part of its mission the provision of high quality, timely data to the NCI Community Oncology Research Program (NCORP) Research Bases in a research environment that sets the highest standards for the safety and welfare of the clinical trials’ participants. NCRF will continue to enroll patients/participants on NCI clinical trials and plans to exceed the required annual 80 new unique patient/participant accruals evenly distributed between cancer control, prevention, and screening/post-treatment surveillance trials, and treatment and imaging trials, respectively that is required for participation in NCORP. NCRF also plans to participate in at least three cancer care delivery protocols annually and to continue to participate in bio-specimen collection for biobanks that serve as scientific resources for the NCORP Research Bases. NCRF plans to actively work with the NCI to develop an integrated community-based research network in order to reduce the cancer incidence, morbidity, and mortality in Nevada by accelerating the transfer of newly developed cancer prevention, early detection, treatment, patient management rehabilitation, quality of life, and continuing care technology. NCRF will involve NCRF staff and physicians in the scientific and educational activities of the Research Bases and will participate in studies to enhance participation of racial/ethnic and other underserved populations underrepresented in research. To accomplish these goals, the NCRF opens the program for state-wide participation, thereby providing access for participation to the residents of Nevada.

内华达癌症研究基金会 (NCRF) 成立于 1983 年，旨在开展癌症研究。 NCRF 总部位于拉斯维加斯，在内华达州里诺市和卡森市设有卫星办事处， 加利福尼亚州阿罗约格兰德和密歇根州休伦港。超过80%的肿瘤科医生、血液科医生和 内华达州的放射肿瘤科医生是 NCRF 的研究成员并参与 NCI 临床 试验和项目。 NCRF 的主要使命是在以下地区提供优质和最先进的癌症治疗 内华达州通过参与内华达州居民积极的癌症研究 当地医生和卫生保健提供者的参与。 NCRF 也将其作为其一部分 使命是向 NCI 社区肿瘤​​学研究提供高质量、及时的数据 计划 (NCORP) 研究基地设立了最高标准的研究环境 临床试验参与者的安全和福利。 NCRF将继续招生 参加 NCI 临床试验的患者/参与者并计划超过每年 80 名新患者 独特的患者/参与者收益均匀分布在癌症控制、预防和 筛查/治疗后监测试验，以及治疗和影像学试验，分别 是参与 NCORP 所必需的。 NCRF 还计划参与至少三项癌症研究 每年制定护理服务方案并继续参与生物样本采集 生物库作为 NCORP 研究基地的科学资源。 NCRF 计划 积极与 NCI 合作，开发一个基于社区的综合研究网络 旨在通过加速癌症治疗来降低内华达州的癌症发病率、发病率和死亡率 转让新开发的癌症预防、早期发现、治疗、患者管理 康复、生活质量和持续护理技术。 NCRF 将涉及 NCRF 工作人员 和医生参与研究基地的科学和教育活动，并将 参与研究以提高种族/族裔和其他服务不足的群体的参与度 研究中代表性不足的人群。为了实现这些目标，NCRF 开设了 全州参与计划，从而为居民提供参与机会 内华达州。

项目成果

Elective Checkpoint Inhibitor Discontinuation in Metastatic Solid Tumor Patients: A Case Series.

转移性实体瘤患者选择性停用检查点抑制剂：病例系列。

• DOI: 10.29011/2574-7754.100894
• 发表时间: 2022
• 期刊: Annals of case reports
• 作者: Lopez-Flores,Ruby;Samlowski,Wolfram;Perez,Leanne
• 通讯作者: Perez,Leanne

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).

新诊断的原位导管癌的术前乳腺 MRI：多中心环境中的成像特征和性能（ECOG-ACRIN E4112 试验）。

• DOI: 10.1148/radiol.2021219016
• 发表时间: 2021
• 期刊: Radiology
• 影响因子: 19.7
• 作者: Chou,Shinn-HueyS;Romanoff,Justin;Lehman,ConstanceD;Khan,SeemaA;Carlos,Ruth;Badve,SunilS;Xiao,Jennifer;Corsetti,RalphL;Javid,SaraH;Spell,DerrickW;Han,LindaK;Sabol,JenniferL;Bumberry,JohnR;Gareen,IlanaF;Snyder,Bradley
• 通讯作者: Snyder,Bradley

Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial.

• DOI: 10.1016/j.euo.2020.07.001
• 发表时间: 2020-12
• 期刊: European urology oncology
• 影响因子: 8.2
• 作者: Bryce AH;Chen YH;Liu G;Carducci MA;Jarrard DM;Garcia JA;Dreicer R;Hussain M;Eisenberger MA;Plimack ER;Vogelzang NJ;DiPaola RS;Harshman L;Sweeney CJ
• 通讯作者: Sweeney CJ